Search results
Brokerage maintains buy on AstraZeneca shares, sees growth potential By Investing.com
Investing.com· 16 hours agoOn Friday, TD Cowen affirmed its positive stance on AstraZeneca (NASDAQ:AZN), maintaining a Buy...
Deutsche Bank maintains 'Hold' on AstraZeneca post ASCO conference By Investing.com
Investing.com· 3 days agoOn Monday, Deutsche Bank (ETR:DBKGn) reiterated a Hold rating and a price target of GBP110.00 on...
AstraZeneca completes acquisition of biopharma company Fusion Pharma
dpa international via Yahoo Finance· 3 days agoBritish pharmaceutical company AstraZeneca on Wednesday announced the completion of the acquisition...
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 3 days agoOn Wednesday, Citi reaffirmed its Buy rating on AstraZeneca (NASDAQ:AZN) shares with a steady price...
AstraZeneca completes Fusion Pharmaceuticals acquisition
Pharmaceutical Technology via Yahoo Finance· 3 days agoAstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical...
3 No-Brainer Stocks to Buy in June
Motley Fool via Yahoo Finance· 6 days agoBut what does June bring? Three Motley Fool contributors think the new month should usher in great investing opportunities. Here's why they picked AbbVie...
AstraZeneca invests in Nucleus RadioPharmaceuticals - Minneapolis / St. Paul Business Journal
The Business Journals· 1 day agoAfter completing a $56 million Series A funding round in 2023, Nucleus RadioPharma scored an...
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
CNBC· 17 hours agoPatients with musculoskeletal conditions who like to stay in their pajamas received some welcome...
Astrazeneca (AZN) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo Finance· 4 days agoAstrazeneca (AZN) closed the most recent trading day at $78.99, moving +1.24% from the previous...
Data Science Hiring Process at AstraZeneca
Analytics India Magazine· 3 days agoWith over 45 years of presence in India, British-Swedish pharmaceutical and biotechnology giant AstraZeneca has data science and AI capabilities deeply ingrained across its ...